Concepedia

Author

Jacopo Polvere

University of SienaORCID

Also Known As

Jacopo Polvere, Polvere, Jacopo

23

Publications

288

Citations

10

H-Index

16

Concepts

All Affiliations

University of SienaUniversity of PisaAzienda Ospedaliera Universitaria Senese
JP

About

Jacopo Polvere is an author at University of Siena specializing in autoimmunity, vaccine development, and viral immunity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

47

2

Immunology

2

2

47

3

Autoimmunity

2

2

47

4

Humoral Immunity

1

1

19

5

Immune Function

1

1

19

Jacopo Polvere

×

10

Publications

261

Citations

10

H-Index

YearCitations

Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine

Annalisa Ciabattini, G Pastore, Fabio Fiorino,

Frontiers in Immunology

2021

109

The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose

Fabio Fiorino, Anna Sicuranza, Annalisa Ciabattini,

Biomedicines

2021

28

B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV

Jacopo Polvere, Massimiliano Fabbiani, G Pastore,

Communications Medicine

2023

25

The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients

Fabio Fiorino, Annalisa Ciabattini, Anna Sicuranza,

Frontiers in Immunology

2022

20

Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine

Annalisa Ciabattini, G Pastore, Fabio Fiorino,

2021

19

A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses

Elena Pettini, Annalisa Ciabattini, G Pastore,

Blood Advances

2022

17

Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine

Annalisa Ciabattini, G Pastore, Simone Lucchesi,

Cells

2023

12

Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a machine learning approach

Giorgio Montesi, Matteo Augello, Jacopo Polvere,

Journal of Translational Medicine

2024

11

The slower antibody response in myelofibrosis patients after two doses of mRNA SARS-CoV-2 vaccine calls for a third dose

Fabio Fiorino, Anna Sicuranza, Annalisa Ciabattini,

2021

10

Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses

Annalisa Ciabattini, Elena Pettini, Fabio Fiorino,

EBioMedicine

2025

10

Page 1